. 2022 Apr 14;19(8):4782. doi: 10.3390/ijerph19084782

Table 5.

Psychiatric drugs consumption in areas with social transformation needs in the pre-COVID-19 and the COVID-19 period.

	Areas with Social Transformation Needs					Areas with No Social Transformation Needs
Consumption (DHD)	Period	Mean	S.D. *	p-Value **	Rosenthal Test	Mean	S.D. *	p-Value **	Rosenthal Test
Anxiolytics	COVID	49.2	25.2	0.17	−0.55	51.89	21.9	0.001	−0.85
Anxiolytics	Pre-COVID	46.9	23.4	0.17	−0.55	48.18	21.5	0.001	−0.85
Hypnotic-sedatives	COVID	22.0	14.8	0.46	−0.29	30.84	16.2	0.001	−0.73
Hypnotic-sedatives	Pre-COVID	21.5	13.8	0.46	−0.29	29.21	15.8	0.001	−0.73
Antidepressants	COVID	36.7	32.6	0.45	−0.30	66.46	38.9	0.001	−0.61
Antidepressants	Pre-COVID	37.0	33.7	0.45	−0.30	64.69	38.4	0.001	−0.61

* standard deviation ** Wilcoxon test.